Thomas C. Reynolds, Chief Medical Officer at SEATTLE GENETICS INC /WA (SGEN), sold 25,000 shares at $12.95 ($324K) on 2010-05-03, disclosed to the SEC on 2010-05-05.
Scheduled sale ($324k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.95 | 1,797 | $23K | 7.2% |
| 2 | $12.95 | 23,203 | $300K | 92.8% |
| Total | $12.95 avg | 25,000 | $324K | 100% |
| Filing → |
| SGEN | SELL | 2013-01-17 | $3.5M | — | Filing → |
| SGEN | SELL | 2012-12-10 | $1.7M | — | Filing → |
| SGEN | SELL | 2012-12-06 | $1.0M | — | Filing → |